Fluvirin is a vaccine against the flu (influenza). Our lawyers are evaluating lawsuits for individuals who developed severe side effects of Fluvirin, such as Guillain-Barré Syndrome (GBS) or a Shoulder Injury Related to Vaccine Administration (SIRVA).
Fluvirin® is an egg-based flu shot that helps protect against three strains of influenza.
How is Fluvirin Given?
Fluvirin is given in a single 0.5-mL injection with a needle into the deltoid muscle of the upper arm, near the shoulder.
Can Fluvirin Cause SIRVA?
Yes. Fluvirin is administered with a needle, so it can potentially cause a Shoulder Injury Related to Vaccine Administration (SIRVA) if the needle is injected improperly into the shoulder. This can result in permanent disability.
Symptoms of SIRVA After Fluvirin Vaccine
- Arm pain
- Shoulder pain
- Intense, stabbing pain
- Shoulder dysfunction
- Limited range of motion
- Lack of flexibility
Can Fluvirin Cause Guillain-Barré Syndrome (GBS)?
Yes. Fluvirin, like all flu shots, is associated with a rare but severe side effect known as Guillain-Barré Syndrome (GBS). This side effect causes rapidly-progressing nerve damage and paralysis in the first few months after receiving the vaccine.
You may be eligible for up to $250,000 if you were diagnosed with a shoulder injury or Guillain-Barré Syndrome after receiving Fluvirin. Our lawyers help victims of flu shot injuries file claims with the Vaccine Injury Compensation Program (VICP).
What is the VICP?
The VICP pays out millions of dollars to hundreds of people who are injured by vaccines every year. The program is funded by a $0.75 tax on the sale of every vaccine and it has existed since the 1980s.
Over $70 Million Paid in SIRVA Lawsuits Since 2011
The VICP has paid out roughly $70 million to around 500 people who were diagnosed with shoulder injuries (SIRVA) after vaccines. Even more money has been paid to people with Guillain-Barré Syndrome and other severe side effects from vaccines. The average payout for a SIRVA lawsuit is $140,000, but the maximum is $250,000 per person.